These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7244840)

  • 1. [Hemodynamic action of curantil in ischemic heart disease].
    Zaslavskaia RM; Zolotaia RD
    Sov Med; 1981; (3):80-3. PubMed ID: 7244840
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of curantil and heparin on indices of microcirculatory and blood oxygen balance in ischemic heart disease].
    Denisiuk VI
    Vrach Delo; 1982; (10):26-9. PubMed ID: 7179876
    [No Abstract]   [Full Text] [Related]  

  • 3. [Mechanisms of the hemodynamic effects of nonachlazine in ischemic heart disease patients].
    Zaslavskaia RM; Zolotaia RD; Olevskiĭ IKh; Duda SG; Vilkovyskiĭ FA
    Farmakol Toksikol; 1986; 49(6):73-7. PubMed ID: 3817152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hemodynamic assessment of anti-angina preparations in treating patients with ischemic heart disease with hypertension].
    Iunusov RA; Burykh LN; Sviridova NI
    Vrach Delo; 1987 Aug; (8):25-7. PubMed ID: 3686955
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dipyridamole (curantil) treatment of anginal patients: results of treatment for many years].
    Anikin VV
    Ter Arkh; 1999; 71(8):34-7. PubMed ID: 10515033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness of combined treatment of coronary disease with curantil and corhormone].
    Kuz'ko NV
    Vrach Delo; 1976 Feb; (2):11-3. PubMed ID: 1266131
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of the vasodilator effect of kurantil and no-spa in population and twin studies].
    Zolotaia RD; Zaslavskaia RM; Lil'in ET
    Farmakol Toksikol; 1984; 47(3):62-6. PubMed ID: 6376164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic changes during treatment with isodinit, sectral, stenopril and kratemon].
    Stankusheva G; Draganov V; Manolov P
    Vutr Boles; 1987; 26(2):33-8. PubMed ID: 3604194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Correction of hemodynamic and metabolic disorders in patients with ischemic heart disease].
    Bondarenko IP
    Vrach Delo; 1988 Mar; (3):31-4. PubMed ID: 3394292
    [No Abstract]   [Full Text] [Related]  

  • 10. [Secondary prevention of ischemic heart disease].
    Khamidov NKh; Dodobaeva MS
    Klin Med (Mosk); 1991 Jan; 69(1):61-3. PubMed ID: 2023397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dipyridamole on myocardial clearance of RB 86 and on some parameters of central hemodynamics in man affected by coronary heart disease.
    de Ponti C; Bardi U
    Acta Cardiol; 1972; 27(3):365-82. PubMed ID: 4538101
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic effects of ceruletide administered intravenously to coronaropathic patients.
    Martini A; Pacciarini MA; Binaghi G; Repetto S; Brunetta F
    Farmaco Sci; 1982 Aug; 37(8):543-7. PubMed ID: 7128811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative prophylactic digitalization of patients with coronary artery disease--a randomized echocardiographic and hemodynamic study.
    Pinaud ML; Blanloeil YA; Souron RJ
    Anesth Analg; 1983 Oct; 62(10):865-9. PubMed ID: 6614518
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemodynamic changes induced by amiodarone in patients with ischemic heart disease].
    Rizzon P; Biasco G; Brindicci G; Antonelli G; Miccoli A
    Boll Soc Ital Cardiol; 1973; 18(3):226-31. PubMed ID: 4807062
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hemodynamic changes caused by amiodarone in patients with ischemic heart disease].
    Biasco G; Miccoli A; Rizzon P
    Boll Soc Ital Cardiol; 1972; 17(7):401-6. PubMed ID: 4650834
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of fenicaberan and xavin on peripheral hemodynamic and blood coagulability indices in patients with chronic ischemic heart disease].
    Shpak BIu; Neĭko EM; Debenklo MV; Lazho AS; Duma ZV
    Vrach Delo; 1988 Mar; (3):34-6. PubMed ID: 3394293
    [No Abstract]   [Full Text] [Related]  

  • 17. [The clofibrate-dipyridamole combination in the prevention and therapy of arteriosclerotic vascular disease and its complications].
    Cucinotta D; Ferretti PG; Daccò L; Mazzera F
    G Clin Med; 1977; 58(11-12):475-86. PubMed ID: 608558
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evaluation of the hemodynamic effects of acute infusion and short-term treatment with creatine phosphate].
    Acito P; Busi F; Moscatelli G; Riva P
    Clin Ter; 1984 Dec; 111(5):427-33. PubMed ID: 6240369
    [No Abstract]   [Full Text] [Related]  

  • 19. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of finoptin on cerebrocardiac correlations in atherosclerotic circulatory encephalopathy in patients with ischemic heart disease].
    Dubenko OE; Ermakovich II
    Vrach Delo; 1988 Mar; (3):39-42. PubMed ID: 3394295
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.